Evidence map›Paper›PMID 18753296›Full record

ArticleAmerican journal of physiology. Renal physiology2008

Interleukin-18 binding protein transgenic mice are protected against ischemic acute kidney injury.

Zhibin He, Lawrence Lu, Christopher Altmann, Thomas S Hoke, Danica Ljubanovic, Alkesh Jani, Charles A Dinarello, Sarah Faubel, Charles L Edelstein

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Renal physiology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 76 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. IL-18 and IL-18BP: A Unique Dyad in Health and Disease.International journal of molecular sciences · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. A comprehensive pathway map of IL-18-mediated signalling.Journal of cell communication and signaling · 2020
    Article
  10. Article
  11. Biomarkers of Drug-Induced Kidney Toxicity.Therapeutic drug monitoring · 2019
    Review
  12. Interleukin-18 in Health and Disease.International journal of molecular sciences · 2019
    Review
  13. Interleukin-18 binding protein attenuates renal injury of adriamycin-induced mouse nephropathy.International journal of clinical and experimental pathology · 2019
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Cytokine production increases and cytokine clearance decreases in mice with bilateral nephrectomy.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2012
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Zhibin HeDepartment of Medicine, University of Colorado Health Sciences Center, Denver, CO 80262, USA.
Lawrence Lu
Christopher Altmann
Thomas S Hoke
Danica Ljubanovic
Alkesh Jani
Charles A Dinarello
Sarah Faubel
Charles L Edelstein
University of Colorado Health · US

Funding

ROLE OF CASPASES IN ISCHEMIC ACUTE RENAL FAILURER01DK056851 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI EDELSTEIN, CHARLES LOUIS · 2001 to 2010
$2.5M
The Role of IL-18 in Ischemic Acute Renal FailureK08DK065022 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI FAUBEL, SARAH · 2003 to 2007
$658k
The role of macrophages and natural killer cells in cisplatin-induced acute renalF32DK079547 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI LU, LAWRENCE · 2007 to 2007
$57k
NIDDK NIH HHS F32 DK-079547-01NIDDK NIH HHS K08 DK-0695121NIDDK NIH HHS K08 DK-65022NIDDK NIH HHS R01 DK-56851
6 · The paper itself

Abstract

IL-18 function is neutralized in IL-18 binding protein transgenic (IL-18BP Tg) mice. First, we determined whether IL-18BP Tg mice are protected against ischemic acute kidney injury (AKI). Ischemic AKI was induced by bilateral renal pedicle clamping. IL-18BP Tg mice were functionally and histologically protected against ischemic AKI as determined by blood urea nitrogen, serum creatinine, and acute tubular necrosis score. We have demonstrated that the injurious effect of IL-18 in the kidney is independent of neutrophils and lymphocytes. Thus the effect of IL-18 inhibition on renal macrophage infiltration was determined. The number of macrophages was significantly reduced in IL-18BP Tg compared with wild-type kidneys. To determine the cytokines and chemokines that are dependent on IL-18, we performed flow cytometry based assays. Multiple chemokines/cytokines, IL-3, IL-6, IL-15, IL-18, leukemia inhibitory factor, macrophage colony-stimulating factor, macrophage inflammatory protein-2, granulocyte-macrophage colony-stimulating factor, and monocyte chemotactic protein-1 were significantly increased in AKI vs. sham kidneys. Only CXCL1 (also known as KC or IL-8) was significantly increased in AKI vs. sham kidneys and significantly reduced in IL-18BP Tg AKI vs. wild-type AKI kidneys. To determine whether macrophages are the source of CXCL1 in the kidney, we depleted macrophages with liposomal encapsulated clodronate. CXCL1 was significantly decreased in macrophage-depleted vs. control AKI mice. In summary, in ischemic AKI in mice, 1) IL-18BP Tg mice are functionally and histologically protected, 2) macrophage infiltration in the kidney and CXCL1 are significantly reduced in IL-18BP Tg mice, and 3) macrophage depletion significantly reduces CXCL1 in the kidney. In conclusion, protection against ischemic AKI in IL-18BP Tg mice is associated with less macrophage infiltration and less production of CXCL1 in the kidney.

Indexed as

Acute DiseaseAnimalsApoptosisBlood Urea NitrogenCD11b AntigenCell CountChemokine CXCL1ChemokinesCreatinineCytokinesFlow CytometryHumansIntercellular Signaling Peptides and ProteinsInterleukin-18KidneyKidney DiseasesCD11b AntigenChemokine CXCL1ChemokinesCreatinineCxcl1 protein, mouseCytokinesIntercellular Signaling Peptides and ProteinsInterleukin-18interleukin-18 binding protein

Identifiers

PMID18753296
PMCPMC2584896
OpenAlexW2106414700

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.